Company / Revenue
Traws Pharma, Inc. Revenue History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$226.0K
FY2024
5-year range
$226.0K / $2.2M
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $226,000 in FY2024 to $11M in FY2016.
Based on SEC 10-K filings.
$226,000 in FY2024 with a 5-year CAGR of -28.7%.
Remained stable around $226,000 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- -28.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -28.7%, indicating a declining trend.
- In FY2024, revenue increased 0.0% year-over-year.
- Peak revenue was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $226.0K | +0.0% |
| FY2023 | $226.0K | +0.0% |
| FY2022 | $226.0K | -2.2% |
| FY2021 | $231.0K | -89.4% |
| FY2020 | $2.2M | +77.8% |
| FY2019 | $1.2M | +56.0% |
| FY2018 | $787.0K | -85.8% |
| FY2017 | $5.5M | -51.6% |
| FY2016 | $11.5M | +1332.0% |
| FY2015 | $800.0K | -98.3% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026